A technology that promises efficiency and accuracy while testing COVID-19 cases is on the verge of being certified for global use. With this, it takes only 80 minutes for doctors to confirm if a patient is coronavirus positive or not.
The licenses for this technology is now being offered to pharmaceutical and diagnostic kit manufacturers for the production of Master Mix used in COVID-19 Real Time PCR Kit and Viral Inactivation Fluid (VIF).
The brains behind the technology, (Tesscorn Seasia, a Singapore-based firm part of Tesscorn Systems headquartered in Bengaluru) vouches for 100 per cent sensitivity and specificity for a fast-track result while checking if a person has COVID-19 or not.
COVID-19 RT-PCR is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 in upper and lower respiratory specimens.
These samples are collected from individuals suspected of having COVID-19 by healthcare officials.
Every kit includes an internal control (also known as Master Mix) targeting RNase P (a type of ribonuclease), which is needed to verify that nucleic acid is present in every sample and is used for every sample processed.
Discussion about this post